Skip to main content
SpringerLink
Log in

Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokinetics

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Three-hour sessions of differential reinforcement of low-rate behavior (DRL 45-s) in rats were used to investigate alprazolam, caffeine, and their interactions at the onset, peak and disappearance of serum alprazolam, while caffeine level remained constant. The dose-response curve (DRC) method of Pöch permitted an extensive evaluation of the kind (additivity or independence) of interactions occurring in combined drug effects. The alprazolam and caffeine DRCs were used to derive theoretical additive and independent relations, and the observed combined effects compared to these functions. Behavior-time profiles of the combined effects were similarly compared. Serum alprazolam and caffeine concentrations correlated with their respective behavior-time profiles. No acute tolerance was observed either for the individual drugs or their combinations. Alprazolam was more potent than caffeine in disrupting DRL behavior. Because alprazolam is much shorter-lived (t1/2=32 min) than caffeine (t1/2=3 h) in rats, potency ratios between alprazolam and caffeine changed across session time (from 123 to 4), which determined the expression of the combined effects. Although the combined effects were not distinguishable in terms of additivity or independence in both the DRCs and in the behavior-time profiles, they showed neither synergism nor antagonism. The pharmacokinetics of alprazolam were not altered by caffeine, but those of caffeine were affected by alprazolam.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aldridge A, Parsons WD, Neims AH (1977) Stimulation of caffeine metabolism in the rat by 3-methylcholanthrene. Life Sci 21: 967–974

    Article  PubMed  Google Scholar 

  • Baldwin H, File S (1989) Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors. Pharmacol Biochem Behav 32: 181–186

    Article  PubMed  Google Scholar 

  • Beer B, Chasin M, Clody DE, Vogel JR, Horowitz ZP (1972) Cyclic adenosine monophosphate phosphodiesterase in brain: effect on anxiety. Science 176: 428–430

    PubMed  Google Scholar 

  • Berthou FB, Goasduff T, Dreano Y, Menez J (1995) Caffeine increases its own metabolism through cytochrome P4501A induction in rats. Life Sci 57: 541–549

    Article  PubMed  Google Scholar 

  • Bourne DWA (1989) Boomer, a simulation and modeling program for pharmacokinetic and pharmacodynamic data analysis. Comput Meth Prog Biomed 29: 191–195

    Article  Google Scholar 

  • Canon JG, Lippa AS (1977) Use of DRL in differentiating anxiolytic and neuroleptic properties of CNS drugs. Pharmacol Biochem Behav 6: 591–594

    Google Scholar 

  • Coffin VL, Spealman RD (1985) Modulation of the behavioral effects of chlordiazepoxide by methylxanthines and analogs of adenosine in squirrel monkeys. J Pharmacol Exp Ther 235: 724–728

    PubMed  Google Scholar 

  • Cook L, Sepinwall J (1975) Behavioral analysis of the effects and mechanisms of action of benzodiazepines. In: Costa E, Greengard P (eds) Mechanism of action of benzodiazepines. Raven Press, New York, pp 1–28

    Google Scholar 

  • Daly JW (1993) Mechanism of action of caffeine. In: Garattini S (ed) Caffeine, coffee, and health. Raven Press, New York, pp 97–150

    Google Scholar 

  • Dawson GW, Jue SG, Brogden RN (1984) Alprazolam. Drugs 27: 132–147

    PubMed  Google Scholar 

  • De Angelis L, Bertolissi M, Nardini G, Traversa U, Vertua R (1982) Interaction of caffeine with benzodiazepines: behavioral effects in mice. Arch Int Pharmacodyn 255: 89–102

    PubMed  Google Scholar 

  • De Lean A, Munson PJ, Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radio-ligand assay, and physiological dose-response curves. Am J Physiol 235: E97-E102

    PubMed  Google Scholar 

  • De Lean A, Munson PJ, Guardabasso V, Rodbard D (1992) A user's guide to ALLFIT. Simultaneous fitting of families of sigmoidal dose response curves using the four-parameter logistic equation. Lab Theoret Physical Biology, Natl Inst Child Health and Human Development, NIH, Bethesda, Md., USA

    Google Scholar 

  • Ellinwood Jr EH, Heatherly DG, Nikaido AM, Bjornsson TD, Kilts C (1985) Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam. Psychopharmacology 86: 392–399

    Article  PubMed  Google Scholar 

  • Falk JL, Lau CE (1991) Synergism by caffeine and by cocaine of the motor control deficit produced by midazolam. Pharmacol Biochem Behav 39: 525–529

    Google Scholar 

  • Fawcett JA, Kravitz HM (1982) Alprazolam. Pharmacotherapy 2: 243–254

    PubMed  Google Scholar 

  • File SE, Bond AJ, Lister RG (1982) Interaction between effects of caffeine and lorazepam in performance test and self-ratings. J Clin Psychopharmacol 2: 102–106

    PubMed  Google Scholar 

  • Ghoneim MM, Hinrichs JV, Chiang C, Loke WH (1986) Pharmacokinetic and pharmacodynamic interactions between caffeine and diazepam. J Clin Psychopharmacol 6: 75–80

    PubMed  Google Scholar 

  • Gilbert RM (1976) Caffeine as a drug abuse. In: Gibbons RJ, Israel Y, Kalant M, Poplan RE, Schmidt W, Smart RG (eds) Research advances in alcohol and drug problems, vol. 3. John Wiley, New York, pp 49–176

    Google Scholar 

  • Greenblatt DJ, Shader RI (1987) Pharmacokinetics of antianxiety agents. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 1377–1386

    Google Scholar 

  • Greenblatt DJ, Wright CE (1993) Clinical pharmacokinetics of alprazolam: therapeutic implications. Clin Pharmacokinet 24: 453–471

    PubMed  Google Scholar 

  • Greenblatt DJ, Shader RI, Abernethy DR (1983) Current status of the benzodiazepines. N Engl J Med 309: 345–358

    Google Scholar 

  • Guengerich FP (1995) Influence of nutrients and other dietary materials on cytochrome P-450 enzymes. Am J Clin Nutr 61: 651S-658S

    PubMed  Google Scholar 

  • Henauer SA, Hollister LE, Gillespie HK, Moore F (1983) Theophylline antagonizes diazepam-induced psychomotor impairment. Eur J Clin Pharmacol 25: 743–747

    Article  PubMed  Google Scholar 

  • Hironaka T, Fuchino K, Fujii T (1984) Absorption of diazepam and its transfer through the blood-brain after intraperitoneal administration in the rat. J Pharmacol Exp Ther 229: 809–814

    PubMed  Google Scholar 

  • Holloway FA, Modrow HE, Michaelis RC (1985) Methylxanthine discrimination in the rat: possible benzodiazepine and adenosine mechanisms. Pharmacol Biochem Behav 22: 815–824

    Article  PubMed  Google Scholar 

  • Holtzman ST (1986) Discriminative stimulus properties of caffeine in the rat: noradrenergic mediation. J Pharmacol Exp Ther 239: 706–714

    PubMed  Google Scholar 

  • Igari Y, Sugiyama Y, Sawada Y, Iga T, Hanano M (1982) Tissue distribution of C-diazepam and its metabolites in rats. Drug Metab Dispos 10: 676–679

    PubMed  Google Scholar 

  • Jin LY, Lau CE (1994) Determination of alprazolam and its major metabolites in serum microsamples by HPLC and its application to pharmacokinetics in rats. J Chromatogr 654: 77–83

    Google Scholar 

  • Kaplan GB, Tai NT, Greenblatt DJ, Shader RI (1990) Separate and combined effects of caffeine and alprazolam on motor activity and benzodiazepine receptor binding in vivo. Psychopharmacology 101: 539–544

    Article  PubMed  Google Scholar 

  • Katims JJ, Murphy KMM, Snyder SH (1983) Xanthine stimulants and adenosine. In: Creese I (ed) Stimulants: neurochemical, behavioral, and clinical perspectives. Raven Press, New York pp 63–79

    Google Scholar 

  • Kramer TJ, Rilling M (1970) Differential reinforcement of low rates: a selective critique. Psych Bull 74: 225–254

    Google Scholar 

  • Latini R, Bonati M, Castelli D, Garattini S (1978) Dose-dependent kinetics of caffeine in rats. Toxicol Lett 2: 267–270

    Article  Google Scholar 

  • Lau CE, Falk J (1991) Sustained synergism by chronic caffeine of the motor control deficit produced by midazolam. Pharmacol Biochem Behav 40: 723–731

    Article  PubMed  Google Scholar 

  • Lau CE, Falk JL (1994) Tolerance to oral and IP caffeine: locomotor activity and pharmacokinetics. Pharmacol Biochem Behav 48: 337–344

    Article  PubMed  Google Scholar 

  • Lau CE, Falk JL, Dolan S, Tang M (1987) Simultaneous determination of flurazepam and five metabolites in serum by HPLC and its application to pharmacokinetic studies in rats. J Chromatogr 423: 251–259

    PubMed  Google Scholar 

  • Lau CE, Ma F, Falk JL (1995) Oral and IP caffeine pharmacokinetics under a chronic food-limitation condition. Pharmacol Biochem Behav 50: 245–252

    Article  PubMed  Google Scholar 

  • Loewe S, Muischnek H (1926) Über Kombinationswirkungen. I. Mitteilung: Hilfsmittel der Darstellung. Naunyn-Schmiedeberg's Arch Exp Pathol Pharmacol 114: 313–326

    Article  Google Scholar 

  • Loke WH, Hinrichs JV, Ghoneim MM (1985) Caffeine and diazepam: separate and combined effects on mood, memory, and psychomotor performance. Psychopharmacology 87: 344–350

    Google Scholar 

  • Marangos PJ, Paul SM, Parma AM, Goodwin FK, Syapin P, Skolnick P (1979) Purinergic inhibition of diazepam binding to rat brain (in vitro). Life Sci 24: 851–858

    Article  PubMed  Google Scholar 

  • Moschitto LJ, Greenblatt DJ (1983) Concentration-independent plasma protein binding of benzodiazepines. J Pharm Pharmacol 35: 179–180

    PubMed  Google Scholar 

  • Owens MJ, Vargas MA, Knight DL, Nemeroff CB (1991) The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal. J Pharmacol Exp Ther 258: 349–356

    PubMed  Google Scholar 

  • Phillis JW (1979) Diazepam potentiation of purinergic depression of central neurons. Can J Physiol Pharmacol 57: 432–435

    PubMed  Google Scholar 

  • Pöch G (1992) Which view, which model, which method for the evaluation of combined effects? Arch Complex Env Studies 4: 1–7

    Google Scholar 

  • Pöch G (1993) Combined effects of drugs and toxic agents: modern evaluation in theory and practice. Springer, Wien, New York

    Google Scholar 

  • Pöch G, Dittrich P, Holzmann S (1990) Evaluation of combined effects in dose-response studies by statistical comparison with additive and independent interactions. J Pharmacol Methods 24: 311–325

    Article  PubMed  Google Scholar 

  • Polc P, Bonetti EP, Pieri L, Cumin R, Angioi RM, Mohler H, Haefely WE (1981) Caffeine antagonizes several central effects of diazepam. Life Sci 28: 2265–2275

    Article  PubMed  Google Scholar 

  • Richards JB, Sabol KE, Seiden LS (1993) DRL interresponse-time distributions: quantification by peak deviation analysis. J Exp Anal Behav 60: 361–385

    PubMed  Google Scholar 

  • Roache J, Griffiths R (1987) Interactions of diazepine and caffeine: behavioral and subjective dose effects in humans. Pharmacol Biochem Behav 26: 801–812

    Google Scholar 

  • Rush CR, Higgins ST, Bickel WK, Hughes JR (1994a) Acute behavioral effects of lorazepam and caffeine, alone and in combination, in humans. Behav Pharmacol 5: 245–254

    PubMed  Google Scholar 

  • Rush CR, Higgins ST, Hughes JR, Bickel WK (1994b) Acute behavioral effects of triazolam and caffeine, alone and in combination, in humans. Exp Clin Psychopharmacol 2: 211–222

    Article  Google Scholar 

  • Sanger DJ (1980) The effects of caffeine on timing behavior in rodents: comparisons with chlordiazepoxide. Psychopharmacology 68: 305–309

    Article  PubMed  Google Scholar 

  • Sethy VH, Francis JW, Elfring G (1987) Onset and duration of action of benzodiazepines as determined by inhibition of (3H)-flunitrazepambinding. Drug Dev Res 10: 117–121

    Article  Google Scholar 

  • Sethy VH, Harris DW (1982) Determination of biological activity of alprazolam, triazolam and their metabolites. J Pharm Pharmacol 34: 115–116

    PubMed  Google Scholar 

  • Stephens DN, Voet B (1994) Differential effects of anxiolytic and non-anxiolytic benzodiazepine receptor ligands on performance of a differential reinforcement of low rate (DRL) schedule. Behav Pharmacol 5: 4–14

    PubMed  Google Scholar 

  • Tang M, Kuribara H, Falk JL (1989) Anxiolytic effect of caffeine and caffeine-clonazepam interaction: evaluation by NaCl solution intake. Pharmacol Biochem Behav 32: 773–776

    Article  PubMed  Google Scholar 

  • Thomas RC, Judy RW (1976) Tissue levels of alprazolam-14C(U-31889) in the mouse as determined by whole body section autoradiography. Upjohn Company

  • Tuncok Y, Akpinar O, Guven H, Akkoclu A (1994) The effects of theophylline on serum alprazolam levels. Int J Clin Pharmacol Ther 32: 642–645

    PubMed  Google Scholar 

  • Ukelbach HD, Poch G (1988) Comparison of independence and additivity in drug combination. Arzneimittelforschung 38: 1–6

    Google Scholar 

  • Valentine JO, Spealman RD (1983) Effects of caffeine and chlordiazepoxide on schedule-controlled responding of squirrel monkeys. Fed Proc 42: 1158

    Google Scholar 

  • von Moltke LL, Greenblatt DJ, Harmatz JS, Shader RI (1993) Alprazolam metabolism in vitro: studies of human, monkey, mouse, and rat liver microsomes. Pharmacology 47: 268–276

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychology, Busch Campus, Rutgers University, 08903, New Brunswick, NJ, USA

    C. E. Lau & J. Wang

Authors
  1. C. E. Lau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lau, C.E., Wang, J. Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokinetics. Psychopharmacology 126, 115–124 (1996). https://doi.org/10.1007/BF02246346

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02246346

Key words

Search

Navigation